Efficacy and Safety of the Selective α(1A)-Adrenoceptor Blocker Silodosin for Severe Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective, Single-Open-Label, Multicenter Study in Korea

PURPOSE: To evaluate the efficacy and safety of silodosin 8 mg once daily in a 12-week treatment of subjects with severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: A total of 100 subjects from 10 urology centers in Korea were includ...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Moon, Ki Hak, Song, Phil Hyun, Yang, Dae Yul, Park, Nam Cheol, Kim, Soo Woong, Lee, Sung Won, Kim, Sae Woong, Moon, Du Geon, Park, Jong Kwan, Ahn, Tai Young, Park, Kwangsung
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Korean Urological Association 2014
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4026660/
https://ncbi.nlm.nih.gov/pubmed/24868338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/kju.2014.55.5.335
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg